Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved?-Reference-Cited by-同舟云学术

Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved?

Published:2014-03-22 Issue:6 Volume:22 Page:1705-1714
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Biffi Roberto,Toro Adriana,Pozzi Simonetta,Di Carlo Isidoro

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-014-2208-1.pdf

Reference55 articles.

1. Niederhuber JE, Ensminger W, Gyves JW et al (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712

2. Pratt RJ, Pellowe CM, Wilson JA et al (2007) epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 65(suppl):S1–S64

3. Biffi R, De Braud F, Orsi F et al (2001) A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92(5):1204–1212

4. Maki DG, Kluger DM, Cornich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159–1171

5. Hockenhull JC, Dwan K, Boland A et al (2008) The clinical effectiveness and cost effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess 12:1–154

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Classic and Effective Approach for Managing Totally Implantable Venous-Access Port Site Dehiscence in Patients with Cancer: The Limberg Flap;Journal of Wound Management and Research;2024-06-30

2. Chemoport (TIVADs—Totally Implantable Venous Access Devices): Complications and Management;Complications of Cancer Therapy: Best Practices in Prevention and Management;2024

3. A GAVeCeLT bundle for PICC-port insertion: The SIP-Port protocol;The Journal of Vascular Access;2023-11-13

4. Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer;Cancers;2023-04-12

5. Cephalic Vein Cut Down for Total Implantable Venous Access Ports: A Retrospective Review of a Single Institution Series;EJVES Vascular Forum;2023